Polymyalgia rheumatica (PMR) is a rheumatic disease characterized by recurrent inflammatory episodes. PMR is usually seen in Caucasians living in Northern Europe and North America. The condition ...

The Global Healthy Living Foundation (GHLF) is excited to present innovative and transformative research at the American College of Rheumatology (ACR) Convergence 2024 in Washington DC. This marks ...

UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation (GHLF) announced a $1.6 million four-year grant from the Centers for Disease Control and Prevention (CDC) to enhance awareness ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved sarilumab for the treatment of polymyalgia rheumatica in adults who have experienced an ...

Learn about polymyalgia rheumatica, temporal arteritis, their symptoms, causes, and treatment options to manage pain, ...

Topline data were announced from a phase 3 trial evaluating secukinumab in patients with polymyalgia rheumatica.

Autoimmune diseases happen when the body's natural defense mechanisms attack normal healthy cells. Polymyalgia rheumatica--or PMR-- is a rare autoimmune disease most often found in older women of ...

The approval was based on data from a phase 3 study which included adults with steroid-resistant active PMR who flared on at least 7.5mg per day of prednisone or equivalent during taper. The Food and ...

Tofacitinib (Xeljanz) appeared highly effective against polymyalgia rheumatica (PMR) in a small single-arm trial, researchers said, suggesting another potential alternative to long-term ...

In a long-term follow-up study, patients with isolated polymyalgia rheumatica (PMR) and biopsy-confirmed giant cell arteritis (GCA) had no increased all-cause mortality compared with matched ...

THE condition that is called by the English polymyalgia rheumatica and by the French pseudopolyarthrite rhizomélique and has had many synonyms 1 is characterized by pain and stiffness in the muscles ...